Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors

Publisher： Karger

E-ISSN： 1423-0194|103|5|495-499

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.103, Iss.5, 2015-09, pp. : 495-499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors

By  

Neuroendocrinology, Vol. 95, Iss. 2, 2011-12 ,pp. : 120-134

Karger

Access to resources Recommend Favorite

Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma

By  

Neuroendocrinology, Vol. 87, Iss. 1, 2007-12 ,pp. : 8-19

Karger

Access to resources Recommend Favorite

Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Tumour/Carcinoma of the Appendix and Goblet Cell Carcinoma

By  

Neuroendocrinology, Vol. 87, Iss. 1, 2007-10 ,pp. : 20-30

Karger

Access to resources Recommend Favorite

Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Colon and Rectum Tumour/Carcinoma

By  

Neuroendocrinology, Vol. 87, Iss. 1, 2007-11 ,pp. : 31-39

Karger

Access to resources Recommend Favorite

Well-Differentiated Gastric Tumors/Carcinomas

By  

Neuroendocrinology, Vol. 84, Iss. 3, 2007-02 ,pp. : 158-164

Karger

Access to resources Recommend Favorite